We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Glaxo Relents, Grants Mylan Paxil License

Law360 (October 23, 2007, 12:00 AM EDT) -- Mylan Inc. has settled GlaxoSmithKline Plc's infringement suit over Glaxo's blockbuster antidepressant Paxil CR, gaining the right to produce and market all three strengths of its generic version of the drug,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.